XML 43 R33.htm IDEA: XBRL DOCUMENT v3.21.1
GOODWILL AND INTANGIBLE ASSETS (Tables)
 3 Months Ended
Mar. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Goodwill
A reconciliation of changes in the Company’s goodwill by reportable segment were as follows:
(in millions)Technologies & EquipmentConsumablesTotal
Balance at December 31, 2020$3,092 $894 $3,986 
Acquisition related additions33 — 33 
Divestiture of a business— (3)(3)
Measurement period adjustments on prior acquisitions(3)— (3)
Effects of exchange rate changes(47)(14)(61)
Balance at March 31, 2021$3,075 $877 $3,952 

The gross carrying amount of goodwill and the cumulative goodwill impairment were as follows:
March 31, 2021December 31, 2020
(in millions)Gross Carrying AmountCumulative ImpairmentNet Carrying AmountGross Carrying AmountCumulative ImpairmentNet Carrying Amount
Technologies & Equipment$5,968 $(2,893)$3,075 $5,985 $(2,893)$3,092 
Consumables877 — 877 894 — 894 
Total effect of cumulative impairment$6,845 $(2,893)$3,952 $6,879 $(2,893)$3,986 
Schedule of Definite-lived and Indefinite-lived Intangible Assets
Identifiable definite-lived and indefinite-lived intangible assets were as follows:
March 31, 2021December 31, 2020
(in millions)Gross
Carrying
Amount		Accumulated
Amortization		Net
Carrying
Amount		Gross
Carrying
Amount		Accumulated
Amortization		Net
Carrying
Amount
Developed technology and patents$1,702 $(685)$1,017 $1,681 $(677)$1,004 
Tradenames and trademarks269 (70)199 273 (70)203 
Licensing agreements36 (30)6 37 (30)7 
Customer relationships1,112 (500)612 1,142 (494)648 
Total definite-lived$3,119 $(1,285)$1,834 $3,133 $(1,271)$1,862 
Indefinite-lived tradenames and trademarks$616 $— $616 $642 $— $642 
In-process R&D (a)
11 — 11 — — — 
Total indefinite-lived$627 $— $627 $642 $— $642 
Total identifiable intangible assets$3,746 $(1,285)$2,461 $3,775 $(1,271)$2,504 

(a) Intangible assets acquired in a business combination that are in-process and used in research and development ("R&D") activities are considered indefinite-lived until the completion or abandonment of the R&D efforts. The useful life and amortization of those assets will be determined once the R&D efforts are completed.